Filing Flows › Comparisons › WST vs PODD
West Pharmaceutical Services vs Insulet: WST and PODD compared
West Pharmaceutical Services is the larger company: $874M of revenue in its latest quarter (Q3 2026) against $842M for Insulet (Q3 2026). Insulet is growing faster (+19% against +9% a year earlier). West Pharmaceutical Services is more profitable, with an operating margin of 30.6% against 22.5%.
Where the money goes: WST and PODD
West Pharmaceutical Services (WST) · Q3 2026
West Pharmaceutical Services, Q3 2026: revenue $874M (+9% year over year), operating margin 30.6%, net earnings $214M, operating cash flow $190M. The chart follows the revenue to costs, profit and cash.
Insulet (PODD) · Q3 2026
Insulet, Q3 2026: revenue $842M (+19% year over year), operating margin 22.5%, net earnings $141M, operating cash flow $124M. The chart follows the revenue to costs, profit and cash.
| West Pharmaceutical Services (WST) | Insulet (PODD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $874M | $842M |
| Revenue growth, Y/Y | +9% | +19% |
| Gross margin | 39.7% | 75.1% |
| Operating margin | 30.6% | 22.5% |
| Net earnings | $214M | $141M |
| Net margin | 24.5% | 16.8% |
| Operating cash flow | $190M | $124M |
| Free cash flow | $150M | $66.4M |
| Market value | $28.3B | $10.2B |
| P/E | 44.9× | 23.9× |
| Analysts’ mean target | $471.00 | $178.35 |
Where the revenue comes from
West Pharmaceutical Services
- Proprietary Products: $729M (83%)
- West Vantage: $146M (17%)
Insulet
- Total Omnipod products: $837M (99%)
- Drug Delivery: $5.5M (1%)
Questions
Which is bigger, West Pharmaceutical Services or Insulet?
West Pharmaceutical Services is the larger company: $874M of revenue in its latest quarter (Q3 2026) against $842M for Insulet (Q3 2026).
Is West Pharmaceutical Services or Insulet growing faster?
Insulet is growing faster (+19% against +9% a year earlier).
Which is more profitable, West Pharmaceutical Services or Insulet?
West Pharmaceutical Services is more profitable, with an operating margin of 30.6% against 22.5%.
More: West Pharmaceutical Services earnings · how West Pharmaceutical Services makes money · Insulet earnings · how Insulet makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.